How benign is hematuria? Using genetics to predict prognosis (Q38074565)

28 August 2017

1 reference

title

How benign is hematuria? Using genetics to predict prognosis (English)

1 reference

28 August 2017

Daniel P Gale

1

1 reference

28 August 2017

17 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

28

1 reference

28 August 2017

8

1 reference

28 August 2017

1183-1193

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-012-2399-y

28 August 2017

0 references

cites work

Clinical practice. Microscopic hematuria

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

The role of molecular genetics in diagnosing familial hematuria(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Establishing the diagnosis of benign familial hematuria. The importance of examining the urine sediment of family members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Genetic testing in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Comparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Folding delay and structural perturbations caused by type IV collagen natural interruptions and nearby Gly missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Opinion: Ocular features aid the diagnosis of Alport syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Spectrum of clinical features and type IV collagen alpha-chain distribution in Chinese patients with Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Genotype-phenotype correlation in X-linked Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Renal transplantation in patients with Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

The clinical features of thin basement membrane nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Thin basement membrane nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Childhood thin GBM disease: review of 22 children with family studies and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Ruptured intracranial aneurysm in an adolescent with Alport's syndrome--a new expression of type IV collagenopathy: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Aortic abnormalities in males with Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Hereditary macrothrombocytopathia, nephritis and deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Renal manifestations of patients with MYH9-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

HLA has strongest association with IgA nephropathy in genome-wide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Genome-wide association study identifies susceptibility loci for IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Genome-Wide Linkage Scan of a Large Family with IgA Nephropathy Localizes a Novel Susceptibility Locus to Chromosome 2q36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2399-Y

Renal transplantation from living donor parents in two brothers with Alport syndrome. Can asymptomatic female carriers of the Alport gene be accepted as kidney donors?

21 January 2018

1 reference

12 December 2020

Genetic studies of IgA nephropathy

1 reference

12 December 2020

Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4)

1 reference

12 December 2020

Familial clustering of IgA nephropathy: further evidence in an Italian population

1 reference

12 December 2020

Characterization of a large Lebanese family segregating IgA nephropathy

1 reference

12 December 2020

Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis

1 reference

12 December 2020

Renal survival in pediatric patients with IgA nephropathy

1 reference

12 December 2020

Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria

1 reference

12 December 2020

Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese

1 reference

12 December 2020

Thin basement membrane nephropathy: diffuse and segmental types.

1 reference

12 December 2020

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

1 reference

12 December 2020

Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia

1 reference

12 December 2020

IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?

1 reference

12 December 2020

Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy

1 reference

12 December 2020

Thin membrane nephropathy: a clinico-pathological study

1 reference

12 December 2020

Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis

1 reference

12 December 2020

The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities

1 reference

12 December 2020

Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy

1 reference

12 December 2020

Ultrastructural defects of the glomerular basement membranes associated with primary glomerular nephropathies

1 reference

12 December 2020

Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome

1 reference

12 December 2020

Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCP

1 reference

12 December 2020

Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study

1 reference

12 December 2020

Ultrastructural and immunohistochemical findings in Alport's syndrome: a study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations.

1 reference

12 December 2020

Outcome of thirty patients with Alport's syndrome after renal transplantation

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00467-012-2399-Y

Identifiers

DOI

1 reference

PubMed ID

23325022

Dimensions Publication ID

28 August 2017

1006852139

0 references

Fatcat ID

release_cs3uzewylnbnhpvhyqnylp7xte

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cs3uzewylnbnhpvhyqnylp7xte

24 November 2022

mapped directly with Wikidata item

PubMed ID

23325022

1 reference

PubMed ID

23325022